Showing results (331-340 of 533) with videos related to

Sort By:
Pageof 54
The Journal of Infectious Diseases|November 18, 2008
Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancerSophia S Wang, M Concepcion Bratti, Ana Cecilia Rodríguez, et al.
Cancer Research|October 19, 2006
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormalityMelinda Butsch Kovacic, Philip E Castle, Rolando Herrero, et al.
Journal of Gastroenterology and Hepatology|April 20, 2018
Association of circulating inflammation proteins and gallstone diseaseZhiwei Liu, Troy J Kemp, Yu-Tang Gao, et al.
American Journal of Obstetrics and Gynecology|March 14, 2003
Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United StatesSean F Altekruse, James V Lacey, Louise A Brinton, et al.
Multiple Sclerosis and Related Disorders|August 1, 2025
Lost in translation: rethinking animal models of progressive MS (an industry perspective)Florian Von Raison, Paola Zaratin, Martin Stangel, et al.
Occupational and Environmental Medicine|October 23, 2017
Industrial hog farming is associated with altered circulating immunological markersJonathan N Hofmann, Meredith S Shiels, Melissa C Friesen, et al.
Scientific Reports|November 16, 2021
Association between immunologic markers and cirrhosis in individuals with chronic hepatitis BIlona Argirion, Ruth M Pfeiffer, Tram Kim Lam, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)P E Castle, S L Hillier, L K Rabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC familiesKelly J Yu, Wan-Lun Hsu, Ruth M Pfeiffer, et al.
Pageof 54